Patents by Inventor Jung-Hwa OH

Jung-Hwa OH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240219333
    Abstract: The present invention provides an impedance-based organoid evaluation system comprising an organoid deformation generating unit including a first tube and a plurality of second tubes having a diameter smaller than that of the first tube, connected to one end of the first tube or inserted therein; and an impedance measuring unit connected to the organoid deformation generating unit and including an impedance analyzer for measuring the impedance of the organoid, and evaluating the organoid from the impedance measured by the impedance measuring unit.
    Type: Application
    Filed: June 15, 2021
    Publication date: July 4, 2024
    Inventors: Jung-Hwa Oh, Jaehwan Ahn, Seokjoo Yoon, Hyoung-Yun Han, Mi Young Son, Kwang Bo Jung, Cho Rok Jung, Janghwan Kim
  • Publication number: 20240148810
    Abstract: The present invention relates to an anti-inflammatory composition comprising Epimedium koreanum Nakai, Polygala tenuifolia Willd, and Polyporus umbellatus Fries extracts or a mixture thereof as an active ingredient. The extracts and mixture prepared according to the present invention exhibit a high inhibitory effect against nitric oxide and a suppressive effect against the expression of iNOS and COX2 and thus can be advantageously used as an anti-inflammatory composition.
    Type: Application
    Filed: March 19, 2021
    Publication date: May 9, 2024
    Applicant: Korea Research Institute of Chemical Technology
    Inventors: Hyoung-Yun Han, Jung-Hwa Oh, Seokjoo Yoon, Se-Myo Park, Mi-Sun Choi, Soojin Kim
  • Publication number: 20230093162
    Abstract: The present invention relates to a fatty liver and liver fibrosis evaluation system based on impedance. The fatty liver and liver fibrosis evaluation system based on impedance provided in one aspect of the present invention uses 3-dimensional liver microtissues so that the fatty liver formation and the stiffness changes resulted from liver fibrosis induced by a test drug can be analyzed with non-invasive and highly reproducible manner.
    Type: Application
    Filed: November 28, 2022
    Publication date: March 23, 2023
    Applicant: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Jung-Hwa Oh, Jaehwan Ahn, Seokjoo Yoon, Jun-Ho Ahn, Heeyoung Yang, Hyoung-Yun Han
  • Patent number: 10683483
    Abstract: A microfabricated platform for mimicking the liver zonation and an evaluating method of zone-specific hepatotoxicity using the same is provided. The microfabricated platform for mimicking the liver zonation prepared according to the method of the present invention is divided into three zones of zone 1, zone 2 and zone 3 similarly to in vivo liver tissue and thus the zone-specific hepatotoxicity of a drug in the liver can be evaluated using the same. According to the present invention, the zone-specific hepatotoxicity results can be analyzed quantitatively by using image analysis, so that the platform of the present invention can be effectively used for in vitro screening of zone-specific hepatotoxicity.
    Type: Grant
    Filed: March 5, 2019
    Date of Patent: June 16, 2020
    Assignee: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Jung-Hwa Oh, Jaehwan Ahn, Seokjoo Yoon, Heeyoung Yang, Jun-Ho Ahn, Mi-Sun Choi, Soojin Kim, Se-Myo Park, Hyoung-Yun Han
  • Publication number: 20200132670
    Abstract: The present invention relates to a fatty liver and liver fibrosis evaluation system based on impedance. The fatty liver and liver fibrosis evaluation system based on impedance provided in one aspect of the present invention uses 3-dimensional liver microtissues so that the fatty liver formation and the stiffness changes resulted from liver fibrosis induced by a test drug can be analyzed with non-invasive and highly reproducible manner.
    Type: Application
    Filed: April 24, 2019
    Publication date: April 30, 2020
    Applicant: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Jung-Hwa Oh, Jaehwan Ahn, Seokjoo Yoon, Jun-Ho Ahn, Heeyoung Yang, Hyoung-Yun Han
  • Publication number: 20190276799
    Abstract: A microfabricated platform for mimicking the liver zonation and an evaluating method of zone-specific hepatotoxicity using the same is provided. The microfabricated platform for mimicking the liver zonation prepared according to the method of the present invention is divided into three zones of zone 1, zone 2 and zone 3 similarly to in vivo liver tissue and thus the zone-specific hepatotoxicity of a drug in the liver can be evaluated using the same. According to the present invention, the zone-specific hepatotoxicity results can be analyzed quantitatively to by using image analysis, so that the platform of the present invention can be effectively used for in vitro screening of zone-specific hepatotoxicity.
    Type: Application
    Filed: March 5, 2019
    Publication date: September 12, 2019
    Applicant: Korea Research Institute of Chemical Technology
    Inventors: Jung-Hwa OH, Jaehwan AHN, Seokjoo YOON, Heeyoung YANG, Jun-Ho AHN, Mi-Sun CHOI, Soojin KIM, Se-Myo PARK, Hyoung-Yun Han